A carregar...

Development of Novel Radiosensitizers through the National Cancer Institute’s Small Business Innovation Research Program

While radiosensitizing chemotherapy has improved survival for several types of cancer, current chemoradiation regimens remain ineffective for many patients and have substantial toxicities. Given the strong need for the development of novel radiosensitizers to further improve patient outcomes, the Ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Res
Main Authors: Zakeri, Kaveh, Narayanan, Deepa, Prasanna, Pataje G. S., Vikram, Bhadrasain, Buchsbaum, Jeffrey C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266046/
https://ncbi.nlm.nih.gov/pubmed/32216707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15545.1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!